Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
- Status
- COMPLETED
- Phase
- NA
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
- Status
- COMPLETED
- Phase
- PHASE3
The National CT Colonography Trial
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
- Status
- COMPLETED
- Phase
- NA
Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Selenium for Prevention of Adenomatous Colorectal Polyps
- Status
- TERMINATED
- Phase
- PHASE3